Evidence map›Paper›PMID 30733340›Full record

ArticleThe Journal of biological chemistry2019

Protein kinase Cα-mediated phosphorylation of Twist1 at Ser-144 prevents Twist1 ubiquitination and stabilizes it.

Roslyn Tedja, Cai M Roberts, Ayesha B Alvero, Carlos Cardenas, Yang Yang-Hartwich, Sydney Spadinger, Mary Pitruzzello, Gang Yin, Carlotta A Glackin, Gil Mor

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. The complexities of PKCα signaling in cancer.Advances in biological regulation · 2021
    Review
  15. Review
  16. Article
  17. EMT signaling: potential contribution of CRISPR/Cas gene editing.Cellular and molecular life sciences : CMLS · 2020
    Review
  18. Twist1: A Double-Edged Sword in Kidney Diseases.Kidney diseases (Basel, Switzerland) · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Roslyn TedjaFrom the Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut 06511.
Cai M RobertsFrom the Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut 06511.
Ayesha B AlveroFrom the Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut 06511.
Carlos CardenasFrom the Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut 06511.
Yang Yang-HartwichFrom the Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut 06511.
Sydney SpadingerFrom the Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut 06511.ORCID 0000-0002-5160-9794
Mary PitruzzelloFrom the Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut 06511.
Gang Yinthe Department of Pathology, Xiangya Hospital School of Basic Medical Sciences, Central South University, Changsa, Hunan Province 410083, China, and.
Carlotta A Glackinthe Department of Stem Cell and Developmental Biology, City of Hope, Duarte, California 91010.ORCID 0000-0003-2009-3518
Gil MorFrom the Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut 06511, gil.mor@yale.edu.ORCID 0000-0002-5499-3912
Yale University · USCentral South University · CNCity of Hope · US

Funding

Targeting the vascularity for delivery of inhibitors of metastasis in ovarian cancer.R01CA199004 · NCI · YALE UNIVERSITY · PI LIU, HAIPENG, MOR, GIL G · 2015 to 2019
$2.5M
NCI NIH HHS R01 CA199004
6 · The paper itself

Abstract

Twist1 is a basic helix-loop-helix transcription factor that plays a key role in embryonic development, and its expression is down-regulated in adult cells. However, Twist1 is highly expressed during cancer development, conferring a proliferative, migratory, and invasive phenotype to malignant cells. Twist1 expression can be regulated post-translationally by phosphorylation or ubiquitination events. We report in this study a previously unknown and relevant Twist1 phosphorylation site that controls its stability. To identify candidate phosphorylation sites in Twist1, we first conducted an

Indexed as

UbiquitinationEpithelial-Mesenchymal TransitionHEK293 CellsHumansModels, MolecularNuclear ProteinsPhosphorylationProtein Interaction Domains and MotifsProtein Kinase C-alphaProtein StabilityTwist-Related Protein 1Nuclear ProteinsPRKCA protein, humanProtein Kinase C-alphaTWIST1 protein, humanTwist-Related Protein 1embryonic developmentepithelial-mesenchymal transition (EMT)NetphosK3.1ovarian cancerphosphorylationPKCalphapost-transcriptional regulationTwist1ubiquitylation (ubiquitination)

Identifiers

PMID30733340
PMCPMC6442047
OpenAlexW2914156309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.